Weaker osteoclast activity was evident at the bone–tumor interface in tumors with Osx-knockdown cells (arrows), whereas TRAP+ osteoclasts were enriched in bone metastases containing cells overexpressing Osx (Fig. 5e). Here, SP7 is linked to neoplasm.